• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜透析患者:一项系统评价。

in Peritoneal Dialysis Patients: A Systematic Review.

作者信息

Dotis John, Kondou Antonia, Karava Vasiliki, Sotiriou Georgia, Papadopoulou Athina, Zarras Charalampos, Michailidou Chrysi, Vagdatli Eleni, Printza Nikoleta

机构信息

First Department of Pediatrics, Medical Faculty, School of Health Sciences, Aristotle University of Thessaloniki, Hippokration General Hospital, 54642 Thessaloniki, Greece.

Department of Microbiology, Medical Faculty, School of Health Sciences, Aristotle University of Thessaloniki, Hippokration General Hospital, 54642 Thessaloniki, Greece.

出版信息

Pediatr Rep. 2023 Apr 25;15(2):293-300. doi: 10.3390/pediatric15020025.

DOI:10.3390/pediatric15020025
PMID:37218925
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10204424/
Abstract

is a Gram-negative bacillus that can rarely cause infections in humans. We recently treated a case of peritonitis due to in a peritoneal dialysis (PD) pediatric patient, and we systematically reviewed all the relevant reported cases in the literature. We searched the PubMed and Scopus databases, and we reviewed 13 such cases (2 children, 11 adults) that were reported, including our patient. The mean (±SE) age was 53.2 ± 22.5 years, with a male-to-female ratio of approximately 1:1.6. Their mean vintage period on PD prior to peritonitis was 37.5 ± 25.3 months. The VITEK card was the identification diagnostic tool in most cases (63%). The antimicrobial agent that was most frequently used was ceftazidime, which was implemented in 50% of cases as initial therapy, either as a monotherapy or combination therapy; in only two patients (15.3%) was the Tenkhoff catheter removed. The median duration of treatment was 18 days (range of 10-21 days), and all 13 patients that were reviewed were healed. Physicians should be aware that is noted to rarely cause peritonitis in PD patients; however, this pathogen seems to be sensitive to most antimicrobial agents and can result in a favorable outcome with the selection of appropriate treatment.

摘要

是一种革兰氏阴性杆菌,很少能引起人类感染。我们最近治疗了一名腹膜透析(PD)儿科患者因[未提及具体杆菌名称]导致的腹膜炎病例,并系统回顾了文献中所有相关的报告病例。我们检索了PubMed和Scopus数据库,回顾了包括我们的患者在内已报告的13例此类病例(2名儿童,11名成人)。平均(±标准误)年龄为53.2±22.5岁,男女比例约为1:1.6。他们在腹膜炎发生前进行PD的平均透析时间为37.5±25.3个月。在大多数病例(63%)中,VITEK卡是鉴定诊断工具。最常用的抗菌药物是头孢他啶,50%的病例将其作为初始治疗药物,单独使用或联合使用;只有两名患者(15.3%)拔除了Tenkhoff导管。治疗的中位持续时间为18天(范围为10 - 21天),所有接受回顾的13名患者均已治愈。医生应意识到[未提及具体杆菌名称]在PD患者中很少引起腹膜炎;然而,这种病原体似乎对大多数抗菌药物敏感,通过选择合适的治疗方法可取得良好的治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0875/10204424/0e398fac48af/pediatrrep-15-00025-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0875/10204424/0e398fac48af/pediatrrep-15-00025-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0875/10204424/0e398fac48af/pediatrrep-15-00025-g001.jpg

相似文献

1
in Peritoneal Dialysis Patients: A Systematic Review.腹膜透析患者:一项系统评价。
Pediatr Rep. 2023 Apr 25;15(2):293-300. doi: 10.3390/pediatric15020025.
2
as Emerging Pathogen in Human Infections: Clinical Features and Antimicrobial Susceptibility Testing.作为人类感染中的新兴病原体:临床特征与抗菌药敏试验
Pathogens. 2021 Oct 28;10(11):1399. doi: 10.3390/pathogens10111399.
3
Peritonitis from : An emerging pathogen.源自:一种新兴病原体的腹膜炎。
Clin Case Rep. 2019 Mar 18;7(4):829-831. doi: 10.1002/ccr3.2094. eCollection 2019 Apr.
4
Leclercia adecarboxylata peritonitis in a child receiving chronic peritoneal dialysis.一名接受慢性腹膜透析的儿童发生产酸勒克菌腹膜炎。
Pediatr Nephrol. 2000 Dec;15(3-4):186-7. doi: 10.1007/s004670000436.
5
[Catheter colonization by Leclercia adecarboxylata: a pediatric case report].[无丙二酸勒克菌引起的导管定植:1例儿科病例报告]
Arch Argent Pediatr. 2020 Aug;118(4):e418-e420. doi: 10.5546/aap.2020.e418.
6
Leclercia adecarboxylata bacteremia in a trauma patient: case report and review of the literature.创伤患者中去羧基勒克菌血流感染:病例报告及文献复习。
Surg Infect (Larchmt). 2012 Feb;13(1):63-6. doi: 10.1089/sur.2010.093. Epub 2012 Jan 4.
7
Leclercia adecarboxylata: An Emerging Pathogen Among Pediatric Infections.脱羧勒克菌:儿科感染中一种新出现的病原体。
Cureus. 2020 May 10;12(5):e8049. doi: 10.7759/cureus.8049.
8
Leclercia adecarboxylata Sepsis and Cerebral Herniation.脱羧勒克菌败血症与脑疝
J Pediatric Infect Dis Soc. 2014 Mar;3(1):e1-3. doi: 10.1093/jpids/pis131. Epub 2013 Jan 27.
9
Leclercia adecarboxylata as an emerging pathogen in human infections: a 13-year retrospective analysis in Southern Hungary.产脱羧勒克菌在人类感染中的新出现病原体:匈牙利南部 13 年回顾性分析。
J Infect Dev Ctries. 2020 Sep 30;14(9):1004-1010. doi: 10.3855/jidc.12598.
10
invasive infection in a patient with Hirschsprung disease: A case report.先天性巨结肠症患者的侵袭性感染:一例报告
Ann Med Surg (Lond). 2021 Oct 9;71:102927. doi: 10.1016/j.amsu.2021.102927. eCollection 2021 Nov.

引用本文的文献

1
Case report: A rare case of bacteremia in an immunocompetent psychiatric patient: exploring the links between mental health and infectious diseases.病例报告:一例免疫功能正常的精神科患者发生菌血症的罕见病例:探索心理健康与传染病之间的联系。
Front Immunol. 2024 Dec 19;15:1494168. doi: 10.3389/fimmu.2024.1494168. eCollection 2024.
2
Oral Microbial Translocation Genes in Gastrointestinal Cancers: Insights from Metagenomic Analysis.胃肠道癌症中的口腔微生物易位基因:宏基因组分析的见解
Microorganisms. 2024 Oct 18;12(10):2086. doi: 10.3390/microorganisms12102086.
3
Resistance phenotype and virulence potential of strains isolated from different sources.

本文引用的文献

1
ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment.国际腹膜透析学会(ISPD)腹膜炎指南建议:2022年预防与治疗更新版
Perit Dial Int. 2022 Mar;42(2):110-153. doi: 10.1177/08968608221080586.
2
as Emerging Pathogen in Human Infections: Clinical Features and Antimicrobial Susceptibility Testing.作为人类感染中的新兴病原体:临床特征与抗菌药敏试验
Pathogens. 2021 Oct 28;10(11):1399. doi: 10.3390/pathogens10111399.
3
Catheter-Related ESBL-Producing Septicemia in Hemodialysis Patient: An Emerging Pathogen?
从不同来源分离的菌株的耐药表型和毒力潜力。
Microbiology (Reading). 2024 Apr;170(4). doi: 10.1099/mic.0.001457.
血液透析患者中与导管相关的产超广谱β-内酰胺酶败血症:一种新出现的病原体?
Case Rep Infect Dis. 2020 Jan 21;2020:7403152. doi: 10.1155/2020/7403152. eCollection 2020.
4
MALDI-TOF Mass Spectrometry and Specific Biomarkers: Potential New Key for Swift Identification of Antimicrobial Resistance in Foodborne Pathogens.基质辅助激光解吸电离飞行时间质谱与特异性生物标志物:食源性病原体抗菌药物耐药性快速鉴定的潜在新关键
Microorganisms. 2019 Nov 21;7(12):593. doi: 10.3390/microorganisms7120593.
5
Peritonitis from : An emerging pathogen.源自:一种新兴病原体的腹膜炎。
Clin Case Rep. 2019 Mar 18;7(4):829-831. doi: 10.1002/ccr3.2094. eCollection 2019 Apr.
6
Leclercia adecarboxylata: a case report and literature review of 74 cases demonstrating its pathogenicity in immunocompromised patients.产酸克雷伯菌:74 例病例的报告及文献复习,表明其在免疫功能低下患者中有致病性。
Infect Dis (Lond). 2019 Mar;51(3):179-188. doi: 10.1080/23744235.2018.1536830. Epub 2018 Nov 29.
7
Polymicrobial peritonitis with in a peritoneal dialysis patient.一名腹膜透析患者发生的伴有[此处原文缺失内容]的多微生物性腹膜炎。
Saudi J Kidney Dis Transpl. 2017 Jan-Feb;28(1):181-182. doi: 10.4103/1319-2442.198272.
8
Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement.个体参与者数据系统评价和荟萃分析的首选报告项目:PRISMA-IPD 声明。
JAMA. 2015 Apr 28;313(16):1657-65. doi: 10.1001/jama.2015.3656.
9
Leclercia adecarboxylata isolation: case reports and review.去羧勒克菌的分离:病例报告及综述
J Clin Diagn Res. 2014 Dec;8(12):DD03-4. doi: 10.7860/JCDR/2014/9763.5260. Epub 2014 Dec 5.
10
Cycler cassette rupture with Leclercia adecarboxylata peritoneal dialysis peritonitis.携带脱羧勒克菌的腹膜透析相关性腹膜炎伴循环器盒破裂
Perit Dial Int. 2014 Jan-Feb;34(1):131-2. doi: 10.3747/pdi.2012.00253.